<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01497067</url>
  </required_header>
  <id_info>
    <org_study_id>C-09-043</org_study_id>
    <nct_id>NCT01497067</nct_id>
  </id_info>
  <brief_title>Long Term Safety Protocol for the AcrySof CACHET Phakic Lens</brief_title>
  <official_title>Long Term Safety Follow-up for Subjects Previously Implanted With the ACRYSOF® CACHET® Phakic Lens in Clinical Studies C-02-23, C-02-40, C-03-21 and C-05-57</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this long term safety study is to estimate the annualized endothelial cell
      loss (ECL) rate (for up to 10 years following date of implantation) of subjects previously
      implanted with the ACRYSOF CACHET Phakic Intraocular Lens (L-series) from precursor clinical
      studies C-02-23, C-02-40, C-03-21 and C-05-57.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects previously enrolled in protocols C-02-23 (NCT00726024), C-02-40 (NCT00727805),
      C-03-21 (NCT00726297), and C-05-57 (NCT00727688) who received an L-series lens either in the
      first eye or second eye (including those who were explanted) were enrolled in this
      open-label, non-randomized, non-controlled, extension study in which they attended
      postoperative visits for up to 10 years following the date of implantation. Subjects could
      enroll in the study at any time, thus the Entrance Visit may have coincided with any visit
      (Year 4 to Year 10).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 21, 2011</start_date>
  <completion_date type="Actual">June 15, 2018</completion_date>
  <primary_completion_date type="Actual">June 15, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Central Endothelial Cell Density (All Eyes)</measure>
    <time_frame>Year 4 to Year 10 postoperative from previous study (C-02-23, C-02-40, C-03-21, and C-05-57)</time_frame>
    <description>A microscope was used to photograph corneal endothelial cells (cells on the back of the cornea). Three images at the center of the cornea were obtained and sent to a central reading center for analysis. All recorded data from images were used in the analysis. A higher value for density represents a healthier cornea.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">657</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>CACHET</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ACRYSOF CACHET Phakic Lens (L-series) previously implanted</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACRYSOF CACHET Phakic Lens (L-series)</intervention_name>
    <description>Intraocular lens for the treatment of moderate to high myopia</description>
    <arm_group_label>CACHET</arm_group_label>
    <other_name>AcrySof Angle-Supported Phakic Lens</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previously implanted with an ACRYSOF CACHET Phakic Lens (L-Series) from clinical
             studies C-02-23, C-02-40, C-03-21 and C-05-57 and eligible for continued follow-up
             (i.e., exited from the previous study).

          -  Able to understand and sign a statement of informed consent.

          -  Willing and able to complete the yearly postoperative study visits.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sr. Project Lead, Surgical</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Contact Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>December 20, 2011</study_first_submitted>
  <study_first_submitted_qc>December 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2011</study_first_posted>
  <results_first_submitted>June 3, 2019</results_first_submitted>
  <results_first_submitted_qc>June 3, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 26, 2019</results_first_posted>
  <last_update_submitted>June 25, 2019</last_update_submitted>
  <last_update_submitted_qc>June 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Phakic Lens</keyword>
  <keyword>Intraocular Lens (IOL)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 5, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/67/NCT01497067/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 18, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/67/NCT01497067/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This study enrolled subjects at 20 investigative sites located in the US, 9 investigative sites located in the European Union, and 5 investigative sites located in Canada.</recruitment_details>
      <pre_assignment_details>This reporting group includes all enrolled subjects.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CACHET</title>
          <description>ACRYSOF CACHET Phakic Lens (L-series) previously implanted</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="657"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="575"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient decision unrel to Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CACHET</title>
          <description>ACRYSOF CACHET Phakic Lens (L-series) previously implanted</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="657"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.5" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="448"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="209"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="597"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multi-racial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Central Endothelial Cell Density (All Eyes)</title>
        <description>A microscope was used to photograph corneal endothelial cells (cells on the back of the cornea). Three images at the center of the cornea were obtained and sent to a central reading center for analysis. All recorded data from images were used in the analysis. A higher value for density represents a healthier cornea.</description>
        <time_frame>Year 4 to Year 10 postoperative from previous study (C-02-23, C-02-40, C-03-21, and C-05-57)</time_frame>
        <population>All subjects enrolled in the study (Safety Analysis). Some subjects were implanted in both eyes and therefore 2 eyes were enrolled.</population>
        <group_list>
          <group group_id="O1">
            <title>CACHET</title>
            <description>ACRYSOF CACHET Phakic Lens (L-series) previously implanted</description>
          </group>
        </group_list>
        <measure>
          <title>Central Endothelial Cell Density (All Eyes)</title>
          <description>A microscope was used to photograph corneal endothelial cells (cells on the back of the cornea). Three images at the center of the cornea were obtained and sent to a central reading center for analysis. All recorded data from images were used in the analysis. A higher value for density represents a healthier cornea.</description>
          <population>All subjects enrolled in the study (Safety Analysis). Some subjects were implanted in both eyes and therefore 2 eyes were enrolled.</population>
          <units>cells/mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="657"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1123"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Year 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="69"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="80"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2654.0" spread="354.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="259"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="446"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2639.0" spread="324.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 5.5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="65"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="81"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2633.0" spread="357.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="371"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="629"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2551.0" spread="362.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 6.5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="310"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="532"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2524.7" spread="360.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="490"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="803"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2504.9" spread="365.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 7.5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="449"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="726"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2497.1" spread="364.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="567"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="884"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2465.0" spread="384.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 8.5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="492"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="780"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2457.7" spread="363.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 9</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="561"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="856"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2409.6" spread="388.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 9.5</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="544"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="825"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2399.3" spread="387.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Year 10</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="575"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>eyes</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="872"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2377.5" spread="398.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected from time of enrollment until study exit for an individual duration up to 6 years based on time of enrollment.</time_frame>
      <desc>Adverse Events (AE) were obtained through solicited and spontaneous comments from subjects and through observations by the Investigator as outlined in the study protocol. This analysis population includes all subjects enrolled in the study. Number at risk for ocular adverse events is presented with unit eyes.</desc>
      <group_list>
        <group group_id="E1">
          <title>CACHET - Ocular</title>
          <description>All eyes previously implanted with ACRYSOF CACHET Phakic Lens (L-series)</description>
        </group>
        <group group_id="E2">
          <title>CACHET - Systemic</title>
          <description>All subjects previously implanted with ACRYSOF CACHET Phakic Lens (L-series)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="276" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Cataract nuclear</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Cataract subcapsular</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Choroidal neovascularisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Corneal endothelial cell loss</sub_title>
                <counts group_id="E1" subjects_affected="99" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Corneal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Exophthalmos</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Iris adhesions</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Iris atrophy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Iris disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Lens discolouration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Lenticular opacities</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Macular oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Ocular hypertension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Open angle glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Pupillary deformity</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Retinal degeneration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Retinal tear</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Accidental death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Eye complication associated with device</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Dislocation of vertebra</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Visual acuity tests abnormal</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Spinal deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Pituitary tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Throat cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Visual field defect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Corneal operation</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Eye operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Glaucoma surgery</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Intra-ocular injection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Intraocular lens extraction</sub_title>
                <counts group_id="E1" subjects_affected="119" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Intraocular lens implant</sub_title>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Intraocular lens repositioning</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Iridotomy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Iris operation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Keratomileusis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Lens extraction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Retinal laser coagulation</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Retinal operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Retinopexy</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Scleral buckling surgery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Trabeculectomy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Trabeculoplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
              <event>
                <sub_title>Vitrectomy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="657"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sr. Clinical Trial Lead, Surgical</name_or_title>
      <organization>Alcon Research</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

